Pardon me as I scream into a pillow about the fact that Johnson & Johnson slashed Janssen's vaccine R&D and abandoned their adult RSV vaccine even though that protected older adults from severe RSV for *3 seasons* with a single dose:
www.sciencedirect.co...
You can use my screaming pillow! I use it whenever I think about how we had a Lyme Disease vaccine that was pulled from the market because of “low demand” 🙃🙃
From what I can tell from press releases it sounds like they felt like they would be too slow to get to market. Also I expect that the fact that it’s an adenovirus vector had a chilling effect after the cases of VITT/TTS came to light
Ha, thanks. It was more Existential Despair Rhetoric than a real q — I didn’t know the details, but could guess.
I think a lot of people don’t recognize that the vaccine distribution/coverage stuff is…bad now. A longer term is super helpful.
(I had to pay cash for a std vax my doc prescribed. 🤬)
I will never not be mad about that. I’m grateful I had the cash, because I needed it, but that my insurance company made it too hard to access in a timely fashion and the — I forget which agency I contacted — nice regulator said “yeah they can do that, have you considered lobbying?” infuriates me.
It’s kind of futile. VITT is so rare that it’s probably not realistic to get a trial large enough to confirm the safety and to get rid of it would require some engineering of the capsid protein.
www.science.org/doi/10.1126/...
